AstraZeneca acknowledges its covid vaccine, Covishield, can lead to rare blood clot side effects; Here's what we know

Covishield Covid Vaccine: The Covishield COVID-19 vaccine, developed by AstraZeneca in partnership with the University of Oxford, has been acknowledged for its potential to induce a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). This acknowledgment coincides with a legal case alleging severe adverse effects, including fatalities, linked to the vaccine. Kate, the spouse of one affected individual, calls for an apology and just compensation after a three-year ordeal.
Source: The Economic Times - Category: Consumer Health News Source Type: news